Pulmonx
Ophelia Myint is a seasoned customer service professional with extensive experience in managing customer service operations across multiple healthcare technology companies. Currently serving as the Customer Service Manager at Pulmonx Corporation since July 2019, Ophelia has previously held similar managerial roles at Cala Health, Pelvalon, and Benvenue Medical. With a solid foundation in customer service from earlier positions at Asthmatx, Inc. and Surgrx, Ophelia has demonstrated proficiency in order fulfillment, complaint handling, and administrative support within customer service departments. Educational qualifications include a degree from Far Eastern University in the Philippines.
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1